In a recent post Panorama and Seroxat, I highlighted an exchange from ‘The Secrets of Seroxat’ which was broadcast in 2002. Shelley Jofre was quizzing Glaxo’s Alastair Benbow about Seroxat and children – Benbow was fighting the Glaxo corner:
JOFRE: But the evidence here suggest that their children might be at more risk of suicide if they go on Seroxat.
BENBOW: No, the evidence is not there, there is no statistical difference between the groups. The reality of the situation is that in this trial, Seroxat was generally well tolerated by this difficult to treat population.
However, today in its response to Panorama, Glaxo says “The use of Seroxat in children is not recommended, as safety and efficacy have not been established in this population.”
So basically, whenever Seroxat is attacked, Glaxo will say what it needs to, rather than what is true.